Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2017 | May the force be with you: the power of next-generation sequencing

Clinical access to new technologies, such as next-generation sequencing (NGS), can revolutionize the treatment of cancer. In this interview, Guillermo Garcia-Manero, MD, of the University of Texas MD Anderson Cancer Center, Houston, TX, eloquently highlights the potential of NGS for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Dr Garcia-Manero emphasizes the power of this tool for predictive screening, among a range of other utilities. This video was recorded at the American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA.